[18F]2-Fluoro-2-deoxy-d-glucose PET/CT in mediastinal masses
| Autor: | Sheila Rankin |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2010 |
| Předmět: |
medicine.medical_specialty
Thymoma Mediastinal Neoplasms chemistry.chemical_compound thymus Fluorodeoxyglucose F18 Biopsy medicine Focus on: Thoracic mediastinal germ cell tumours Humans Radiology Nuclear Medicine and imaging Radionuclide Imaging Fluorodeoxyglucose PET-CT Radiological and Ultrasound Technology medicine.diagnostic_test business.industry Magnetic resonance imaging General Medicine Thymus Neoplasms Neoplasms Germ Cell and Embryonal medicine.disease Mediastinal Neoplasm FDG-PET/CT Oncology chemistry malignant peripheral nerve sheath tumours Radiology Tomography Radiopharmaceuticals business Nuclear medicine 2-Deoxy-D-glucose medicine.drug |
| Zdroj: | Cancer Imaging |
| ISSN: | 1470-7330 1740-5025 |
| Popis: | Computed tomography (CT) and magnetic resonance imaging (MRI) are excellent modalities for the localization of mediastinal masses and there are often features that may allow the correct diagnosis to be made. However, CT and MRI cannot usually assess the aggressiveness of masses or identify viable tumour in residual masses after chemotherapy. Metabolic imaging using [18F]fluorodeoxyglucose (FDG)-positron emission tomography/CT, although not required in many cases, may be helpful for further characterization of masses and to guide the most appropriate site for biopsy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink